Better treatment outcomes with aripiprazole long-acting injection in community and incarcerated patients with serious mental illness
Datos Bibliográficos
| ID | 15523906 |
|---|---|
| Autores | Erasmia I Koiliari, Ioannis Mouzas (University of Crete), Georgios Alevizopoulos (0000-0001-5573-9476, National and Kapodistrian University of Athens), Otto Lesch (Medical University of Vienna), Hubert Walter (0000-0002-9403-6121, Medical University of Vienna), Henriette Walter, Emmanouil Pasparakis (University of Crete, autor de correspondencia), Emmanouil L Pasparakis |
| Año | 2025 |
| Volumen | 16 |
| Páginas | 1499400-1499400 |
| Fecha de publicación | 2025-08-08 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | Frontiers in Psychiatry (JOURNAL) |
| Identificadores de la revista | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Editorial | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2025.1499400 |
| PMID | 40859936 |
| OpenAlex | W4413248003 |
| Idioma | EN |
| Referencias citadas | 14 |
This study of 34 community and 21 incarcerated patients revealed significant demographic and medical history differences. Both groups experienced reduced hospitalizations and improvements in CGI-S scores and quality of life following aripiprazole LAI administration. Community patients showed a greater reduction in hospitalizations, while clinical and quality-of-life improvements were comparable across groups
Aripiprazole · Clinical Global Impression · Global Assessment of Functioning · Mental health · Mental illness · Psychiatry · Quality of life (healthcare · Schizophrenia (object-oriented programming · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes · Clinical Psychology · Medicine · Schizophrenia research and treatment · Treatment of Major Depression · Internal Medicine
| Velocidad de citación | historical |
|---|---|
| Altamente citado | No |